Related references
Note: Only part of the references are listed.Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes
A. O. Watts et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose
Amrita V. Kamath et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Identification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer
Sanam Mustafa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic
Sashikanth Banappagari et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2012)
The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
Lydia M. Balz et al.
JOURNAL OF PATHOLOGY (2012)
A single ligand is sufficient to activate EGFR dimers
Ping Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling
Qian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways
Byung-Kwon Choi et al.
PROTEIN & CELL (2012)
Application of G Protein-Coupled Receptor-Heteromer Identification Technology to Monitor β-Arrestin Recruitment to G Protein-Coupled Receptor Heteromers
Heng B. See et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies
Gabriele Schaefer et al.
CANCER CELL (2011)
Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles
Enzo R. Porrello et al.
CELLULAR SIGNALLING (2011)
Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF
Hanna Bjorkelund et al.
PLOS ONE (2011)
G Protein-Coupled Receptor Heteromer Identification Technology: Identification and Profiling of GPCR Heteromers
Sanam Mustafa et al.
JALA (2011)
HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy
Marcia R. Campbell et al.
CLINICAL CANCER RESEARCH (2010)
Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization
Mohammed A. Ayoub et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
Yi Zhang et al.
BMC CELL BIOLOGY (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
Natalia Jura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
Predominance of activated EGFR higher-order oligomers on the cell surface
Andrew H. A. Clayton et al.
GROWTH FACTORS (2008)
All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
Rong-Hua Tao et al.
JOURNAL OF CELL SCIENCE (2008)
Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
Kazuko Sakai et al.
CANCER SCIENCE (2007)
Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy
Ping Liu et al.
BIOPHYSICAL JOURNAL (2007)
ErbB receptors: new insights on mechanisms and biology
Bryan Linggi et al.
TRENDS IN CELL BIOLOGY (2006)
Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells
Kevin D. G. Pfleger et al.
CELLULAR SIGNALLING (2006)
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Xuewu Zhang et al.
CELL (2006)
Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response
Harish Shankaran et al.
BIOPHYSICAL JOURNAL (2006)
Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET)
KDG Pfleger et al.
NATURE METHODS (2006)
Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis
AHA Clayton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides
A Suenaga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface
MB Berger et al.
FEBS LETTERS (2004)
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson et al.
MOLECULAR CELL (2003)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The ErbB signaling network: receptor heterodimerization in development and cancer
MA Olayioye et al.
EMBO JOURNAL (2000)
Share Paper
